A8H-16321-84697
4 vaccinations
7 coded responses
29 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Registered in v-safe
-
2021-03-19
Dose 1 — Pfizer-BioNTech
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-24
- 2021-03-26
- 2021-04-02
-
2021-04-09
Dose 2 — Pfizer-BioNTech
- 2021-04-09
- 2021-04-10
- 2021-04-11
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Tremor — Feeling: Good · Site: PainFree text: shakingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Tremor — Feeling: GoodFree text: shakingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
-
2021-05-07
Survey response — day 28, dose 2MedDRA: Menstrual disorder — Feeling: GoodFree text: My period changed. Women are only learning through non-men networks. Please have some non-men participate in the design of your studies going forward.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
- 2021-07-09
- 2021-10-08
-
2021-12-03
Dose 3 — Janssen/Johnson & Johnson
-
2022-04-09
Survey response — 12 months, dose 2MedDRA: Unevaluable event — Feeling: FairFree text: In retrospect, comparing 2019, 2020, 2021 work/life hardship the vaccine in March 2021 probably greatly improved my health re: cognitive over that of 2020. I think we should give the unused paxlovid doses to long covid patients.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Dose 4 — Pfizer-BioNTech
-
2022-10-15
Health check-in — day 7, dose 4Feeling: Good · Site: Pain · Joint pains · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-21
-
2022-10-30
Survey response — day 21, dose 4MedDRA: Rhinorrhoea — Feeling: FairFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Survey response — day 35, dose 4MedDRA: Headache, Neck pain, Paranasal sinus discomfort — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache, neck pain, sinus pressureMedDRA releases: 2024-11 · check-in free text available
- 2023-01-07
-
2023-04-07
Survey response — 6 months, dose 4MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-04-07
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2023-04-11
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-09 | Pfizer-BioNTech | |
| 3 | 2021-12-03 | Janssen/Johnson & Johnson | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): shaking
Systemic reaction (other): shaking
Release 8 — day 28, dose 2
Symptoms: My period changed. Women are only learning through non-men networks. Please have some non-men participate in the design of your studies going forward.
Release 11 — 12 months, dose 2
Symptoms: In retrospect, comparing 2019, 2020, 2021 work/life hardship the vaccine in March 2021 probably greatly improved my health re: cognitive over that of 2020. I think we should give the unused paxlovid doses to long covid patients.
Release 12 — day 21, dose 4
Symptoms: Runny nose
Release 12 — day 35, dose 4
Symptoms: Headache, neck pain, sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Tremor | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release